The Relationship Between Skeletal Muscle Mass and Operative Duration of Pancreaticoduodenectomy Varies by Sex - Report - MDSpire

The Relationship Between Skeletal Muscle Mass and Operative Duration of Pancreaticoduodenectomy Varies by Sex

  • By

  • Sophia Xiao

  • Ashley Freeman

  • Emily Kalmanek

  • Kelsey Steckly

  • Mary Belding-Schmitt

  • Carlos H.F. Chan

  • Erin E. Talbert

  • December 29, 2025

  • 0 min

Share

Clinical Report: The Relationship Between Skeletal Muscle Mass and Operative Duration of Pancreaticoduodenectomy Varies by Sex

Overview

This study investigates the impact of skeletal muscle mass and adipose tissue on the operative duration of pancreaticoduodenectomy, revealing significant differences based on sex. Understanding these relationships may help optimize surgical outcomes and resource utilization.

Background

Pancreaticoduodenectomies are critical surgeries for treating pancreatic malignancies, often complicated by patient obesity and cachexia. The relationship between body composition and surgical outcomes, particularly operative time, is not well understood, despite its potential implications for patient recovery and healthcare efficiency.

Data Highlights

Remove the statement about no numerical data; include relevant statistics if available.

Key Findings

  • Higher BMI is associated with increased intraoperative blood loss and postoperative complications.
  • Longer operative times correlate with worse perioperative outcomes and reduced long-term survival.
  • Body composition, particularly skeletal muscle mass, may significantly influence surgical duration.
  • Adipose tissue's impact on operative time has not been thoroughly characterized but is assumed to extend surgery length.
  • Understanding factors contributing to prolonged operative time could enhance surgical efficiency and patient outcomes.

Clinical Implications

Assessing body composition, particularly skeletal muscle and adipose tissue, may provide valuable insights for preoperative risk evaluation in pancreaticoduodenectomy patients. Optimizing surgical duration could lead to improved patient outcomes and more efficient use of operating room resources.

Conclusion

The study highlights the importance of body composition in determining operative duration for pancreaticoduodenectomy, with potential implications for surgical planning and patient management. Further research is needed to clarify these relationships and their impact on clinical outcomes.

Related Resources & Content

  1. Updates in Surgery, 2023 -- Link Between Long-Term Statin Therapy, Sarcopenia, Myosteatosis, and Significant Morbidity in Surgical Patients with Upper GI Cancer
  2. Updates in Surgery, 2020 -- Evaluation of Skeletal Muscle Mass via Magnetic Resonance Enterography in Crohn's Disease Patients Prior to Surgery
  3. Updates in Surgery, 2021 -- Influence of Body Mass Index on Initial Outcomes of Robotic Pancreaticoduodenectomy
  4. Updates in Surgery — Clinical Considerations of Tumor Location Relative to Major Vessels in Minimally Invasive Radical Antegrade Modular Pancreatosplenectomy
  5. NCCN 2025 Pancreatic Adenocarcinoma Guidelines
  6. Sarcopenia as a prognostic marker in patients undergoing pancreaticoduodenectomy: an updated meta-analysis

Original Source(s)

Related Content